Arcus Biosciences RCUS Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $17M-39.3% | $33M+26.9% | $26M-45.8% | $160M+310% | $28M-80.7% | ||
| $122M0.0% | $121M+19.8% | $141M+14.6% | $139M+20.9% | $122M+11.9% | ||
| $29M+3.6% | $26M-7.1% | $27M-10.0% | $29M-3.3% | $28M-12.5% | ||
| $151M+0.7% | $147M+14.0% | $168M+9.8% | $168M+15.9% | $150M-6.8% | ||
| $151M+0.7% | $147M+14.0% | $168M+9.8% | $168M+15.9% | $150M-6.8% | ||
| -$134M-9.8% | -$114M-10.7% | -$142M-35.2% | -$8M+92.5% | -$122M-663% | ||
| -788.2%-353pp | -345.5%+50.7pp | -546.2%-327pp | -5%+267pp | -435.7%-425pp | ||
| $3M+200% | $2M0.0% | $3M+200% | $2M— | $1M0.0% | ||
| $6M-40.0% | $8M-20.0% | $7M-46.2% | $8M-38.5% | $10M-16.7% | ||
| -$128M-14.3% | -$106M-14.0% | -$135M-46.7% | $0+100% | -$112M-2,700% | ||
| $0— | $0-100% | $0— | $0— | $0— | ||
| -$128M-14.3% | -$106M-12.8% | -$135M-46.7% | $0+100% | -$112M-2,700% | ||
| -752.9%-353pp | -321.2%+40.3pp | -519.2%-328pp | 0%+238pp | -400%-397pp | ||
| -$1.02+10.5% | -$0.90+12.6% | -$1.27-27.0% | $0.00+100% | -$1.14-2,180% | ||
| -$1.02+10.5% | -$0.90+12.6% | -$1.27-27.0% | $0.00+100% | -$1.14-2,180% | ||
| 125.4M+27.4% | 107.4M+19.2% | 106.5M+16.5% | 106.5M+16.9% | 98.4M+14.2% | ||
| 125.4M+27.4% | 107.4M+19.2% | 106.5M+16.5% | 106.1M+16.5% | 98.4M+14.2% | ||
| $9M-18.2% | $10M-16.7% | $10M-28.6% | $10M-23.1% | $11M-15.4% | ||
| -$134M-9.8% | -$114M-10.7% | -$142M-35.2% | -$8M+92.5% | -$122M-663% | ||
| -$132M-10.9% | -$111M-11.0% | -$140M-35.9% | -$6M+94.2% | -$119M-815% | ||
| -$132M-10.9% | -$111M-11.0% | -$140M-35.9% | -$6M+94.2% | -$119M-815% | ||
| -776.5%-351pp | -336.4%+48.3pp | -538.5%-324pp | -3.8%+263pp | -425%-416pp | ||
| -$134M-9.8% | -$114M-10.7% | -$142M-35.2% | -$8M+92.5% | -$122M-663% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Arcus Biosciences's income statement data come from?
- Every line is extracted from Arcus Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.